Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Phytomedicine ; 19(8-9): 699-706, 2012 Jun 15.
Article de Anglais | MEDLINE | ID: mdl-22621780

RÉSUMÉ

Aging is associated with a markedly increased incidence of cardiovascular diseases due, in part, to the development of vascular endothelial dysfunction. The present study has evaluated whether the Crataegus special extract WS(®)1442 prevents the development of aging-related endothelial dysfunction in rats, and, if so, to determine the underlying mechanisms. Wistar rats received either a control diet or the same diet containing 100 or 300 mg/kg/day of WS(®)1442 from week 25 until week 65. Vascular reactivity was assessed in mesenteric artery rings using organ chambers, oxidative stress by dihydroethidine staining and cyclooxygenase-1 (COX-1) and -2 (COX-2) expression by immunohistochemistry. Acetylcholine-induced endothelium-dependent relaxations in mesenteric artery rings were blunted in 65-week-old rats compared to 16-week-old rats. This effect was associated with a marked reduction of the endothelium-derived hyperpolarizing factor (EDHF) component whereas the nitric oxide (NO) component was not affected. Aging was also associated with the induction of endothelium-dependent contractile responses to acetylcholine. Both aging-related impairment of endothelium-dependent relaxations and the induction of endothelium-dependent contractile responses were improved by the Crataegus treatment and by COX inhibitors. An excessive vascular oxidative stress and an upregulation of COX-1 and COX-2 were observed in the mesenteric artery of old rats compared to young rats, and these effects were improved by the Crataegus treatment. In conclusion, chronic intake of Crataegus prevented aging-related endothelial dysfunction by reducing the prostanoid-mediated contractile responses, most likely by improving the increased oxidative stress and the overexpression of COX-1 and COX-2.


Sujet(s)
Vieillissement/physiologie , Endothélium vasculaire/effets des médicaments et des substances chimiques , Endothélium vasculaire/physiologie , Extraits de plantes/pharmacologie , Animaux , Facteurs biologiques/métabolisme , Dérivés du biphényle/pharmacologie , Crataegus , Cyclooxygenase 1/métabolisme , Cyclooxygenase 2/métabolisme , Inhibiteurs des cyclooxygénases/pharmacologie , Acides heptanoïques/pharmacologie , Techniques in vitro , Indométacine/pharmacologie , Mâle , Artères mésentériques/effets des médicaments et des substances chimiques , Relâchement musculaire/effets des médicaments et des substances chimiques , Monoxyde d'azote/métabolisme , Stress oxydatif , Rats , Rat Wistar , Espèces réactives de l'oxygène/métabolisme
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE